[Severe craniocerebral injuries: current therapies].
Boussoffara
M
M
Service d'anesthésie-réanimation, Institut National de Neurologie, Tunis.
Metahni
M K
MK
Skandrani
L
L
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000777:Anesthetics / Q000627:therapeutic use; D000818:Animals; D001463:Barbiturates / Q000627:therapeutic use; D001930:Brain Injuries / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D002245:Carbon Dioxide / Q000097:blood; D002560:Cerebrovascular Circulation; D004234:Diuretics, Osmotic / Q000008:administration & dosage; D006801:Humans; D006982:Hypertonic Solutions / Q000008:administration & dosage; D006985:Hyperventilation; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007036:Hypothermia, Induced; D007552:Isotonic Solutions / Q000008:administration & dosage; D008353:Mannitol / Q000008:administration & dosage; D011187:Posture; D011379:Prognosis; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D000077331:Ringer's Solution; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D000777:Anesthetics; D001463:Barbiturates; D004234:Diuretics, Osmotic; D006982:Hypertonic Solutions; D006993:Hypnotics and Sedatives; D007552:Isotonic Solutions; D002245:Carbon Dioxide; D008353:Mannitol; D000077331:Ringer's Solution
Traumatismes cranio-encéphaliques graves: actualités thérapeutiques.